Margaret Markiewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Margaret Markiewicz has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Maria Trojanowska
Boston University
4 shared publications Natalia Marks
NYP - Columbia University Medical Center, New York, NY 10032, United States
3 shared publicationsAngela Ghatnekar
Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC, USA
2 shared publicationsGary Gilkeson
Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, South Carolina
2 shared publicationsSergey Znoyko
Department of Embriology, Moscow State University, Moscow, Russia
2 shared publications- Anna Ludwicka-Bradley
Division of Rheumatology and Immunology, Medical University of South Carolina, 114 Doughty Street, STB, Charleston, SC 29425, USA
1 shared publication
Latest Publications
- 1 September 2016
- Published by Elsevier in Microvascular Research
- Vol. 107, 76-82
Role of Klotho in migration and proliferation of human dermal microvascular endothelial cells
- 1 September 2016
- Published by Elsevier in Microvascular Research
- Vol. 107, 76-82
Role of Klotho in migration and proliferation of human dermal microvascular endothelial cells
- 31 August 2014
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 40 (06) , 675-681
Are Microparticles the Missing Link between Thrombosis and Autoimmune Diseases? Involvement in Selected Rheumatologic Diseases
Microparticles (MPs) are membrane-bound vesicles with important physiologic effects. MPs exchange information intercellularly, with each kind of MP carrying antigens and receptors of the cells from which they originated. They are biologic effectors in inflammation, angiogenesis, vascular injury, and thrombosis. Thrombosis is generally caused by abnormalities in blood flow, blood composition, and/or properties of the vessel wall. Thrombosis is a well-described feature of cardiovascular disease and cerebrovascular disease. Accumulating evidence suggests that increased risk of thrombosis is also characteristic of autoimmune disorders and immune-mediated diseases affecting all age groups, although the older adults are most vulnerable. Current research has also implicated MPs as a source of autoantigenic nuclear material that can form immune complexes, activate the innate immune system, and may lead to autoimmunity. This review focuses on the contribution of MPs to both the pathogenesis of autoimmune diseases and, as the immune and coagulation systems are tightly linked, their role in hypercoagulability in the setting of autoimmunity in an aging population.
- 31 August 2014
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 40 (06) , 675-681
Are Microparticles the Missing Link between Thrombosis and Autoimmune Diseases? Involvement in Selected Rheumatologic Diseases
Microparticles (MPs) are membrane-bound vesicles with important physiologic effects. MPs exchange information intercellularly, with each kind of MP carrying antigens and receptors of the cells from which they originated. They are biologic effectors in inflammation, angiogenesis, vascular injury, and thrombosis. Thrombosis is generally caused by abnormalities in blood flow, blood composition, and/or properties of the vessel wall. Thrombosis is a well-described feature of cardiovascular disease and cerebrovascular disease. Accumulating evidence suggests that increased risk of thrombosis is also characteristic of autoimmune disorders and immune-mediated diseases affecting all age groups, although the older adults are most vulnerable. Current research has also implicated MPs as a source of autoantigenic nuclear material that can form immune complexes, activate the innate immune system, and may lead to autoimmunity. This review focuses on the contribution of MPs to both the pathogenesis of autoimmune diseases and, as the immune and coagulation systems are tightly linked, their role in hypercoagulability in the setting of autoimmunity in an aging population.
- Open Access
- 28 October 2013
- Published by Wiley in Journal of Aging Research
- Vol. 2013, 1-11
Impact of Endothelial Microparticles on Coagulation, Inflammation, and Angiogenesis in Age-Related Vascular Diseases
Endothelial microparticles (EMPs) are complex vesicular structures that originate from plasma membranes of activated or apoptotic endothelial cells. EMPs play a significant role in vascular function by altering the processes of inflammation, coagulation, and angiogenesis, and they are key players in the pathogenesis of several vascular diseases. Circulating EMPs are increased in many age-related vascular diseases such as coronary artery disease, peripheral vascular disease, cerebral ischemia, and congestive heart failure. Their elevation in plasma has been considered as both a biomarker and bioactive effector of vascular damage and a target for vascular diseases. This review focuses on the pleiotropic roles of EMPs and the mechanisms that trigger their formation, particularly the involvement of decreased estrogen levels, thrombin, and PAI-1 as major factors that induce EMPs in age-related vascular diseases.
- 28 October 2013
- Published by Wiley in Journal of Aging Research
- Vol. 2013, 1-11
Open AccessImpact of Endothelial Microparticles on Coagulation, Inflammation, and Angiogenesis in Age-Related Vascular Diseases
Endothelial microparticles (EMPs) are complex vesicular structures that originate from plasma membranes of activated or apoptotic endothelial cells. EMPs play a significant role in vascular function by altering the processes of inflammation, coagulation, and angiogenesis, and they are key players in the pathogenesis of several vascular diseases. Circulating EMPs are increased in many age-related vascular diseases such as coronary artery disease, peripheral vascular disease, cerebral ischemia, and congestive heart failure. Their elevation in plasma has been considered as both a biomarker and bioactive effector of vascular damage and a target for vascular diseases. This review focuses on the pleiotropic roles of EMPs and the mechanisms that trigger their formation, particularly the involvement of decreased estrogen levels, thrombin, and PAI-1 as major factors that induce EMPs in age-related vascular diseases.
- 1 January 2013
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 133 (1) , 120-127
A Role for Estrogen Receptor-α and Estrogen Receptor-β in Collagen Biosynthesis in Mouse Skin
- 1 January 2013
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 133 (1) , 120-127
A Role for Estrogen Receptor-α and Estrogen Receptor-β in Collagen Biosynthesis in Mouse Skin
- 26 August 2010
- Published by Wiley in Microcirculation
- Vol. 18 (1) , 1-11
Connective Tissue Growth Factor (CTGF/CCN2) Mediates Angiogenic Effect of S1P in Human Dermal Microvascular Endothelial Cells
Please cite this paper as: Markiewicz, Nakerakanti, Kapanadze, Ghatnekar and Trojanowska (2011). Connective Tissue Growth Factor (CTGF/CCN2) Mediates Angiogenic Effect of S1P in Human Dermal Microvascular Endothelial Cells. Microcirculation18(1), 1–11. Abstract Objective: The primary objective of this study was to examine the potential interaction between S1P, a pleiotropic lipid mediator, and CTGF/CCN2, a secreted multimodular protein, in the process of endothelial cell migration. The secondary objective was to determine whether C‐ and N‐terminal domains of CTGF/CCN2 have a specific function in cell migration. Materials and Methods: Migration of HDMECs was examined in monolayer wound healing “scratch” assay, whereas capillary‐like tube formation was examined in three‐dimensional collagen co‐culture assays. Results: We observed that S1P stimulates migration of HDMECs concomitant with upregulation of CTGF/CCN2 expression. Furthermore, the blockade of endogenous CTGF/CCN2 via siRNA abrogated S1P‐induced HDMEC migration and capillary‐like tube formation. Full‐length CTGF induced cell migration and capillary‐like tube formation with a potency similar to that of S1P, while C‐terminal domain of CTGF was slightly less effective. However, N‐terminal domain had only a residual activity in inducing capillary‐like tube formation. Conclusions: This study revealed that CTGF/CCN2 is required for the S1P‐induced endothelial cell migration, which suggests that CTGF/CCN2 may be an important mediator of S1P‐induced physiological and pathological angiogenesis. Moreover, this study shows that the pro‐migratory activity of CTGF/CCN2 is located in the C‐terminal domain.
- 26 August 2010
- Published by Wiley in Microcirculation
- Vol. 18 (1) , 1-11
Connective Tissue Growth Factor (CTGF/CCN2) Mediates Angiogenic Effect of S1P in Human Dermal Microvascular Endothelial Cells
Please cite this paper as: Markiewicz, Nakerakanti, Kapanadze, Ghatnekar and Trojanowska (2011). Connective Tissue Growth Factor (CTGF/CCN2) Mediates Angiogenic Effect of S1P in Human Dermal Microvascular Endothelial Cells. Microcirculation18(1), 1–11. Abstract Objective: The primary objective of this study was to examine the potential interaction between S1P, a pleiotropic lipid mediator, and CTGF/CCN2, a secreted multimodular protein, in the process of endothelial cell migration. The secondary objective was to determine whether C‐ and N‐terminal domains of CTGF/CCN2 have a specific function in cell migration. Materials and Methods: Migration of HDMECs was examined in monolayer wound healing “scratch” assay, whereas capillary‐like tube formation was examined in three‐dimensional collagen co‐culture assays. Results: We observed that S1P stimulates migration of HDMECs concomitant with upregulation of CTGF/CCN2 expression. Furthermore, the blockade of endogenous CTGF/CCN2 via siRNA abrogated S1P‐induced HDMEC migration and capillary‐like tube formation. Full‐length CTGF induced cell migration and capillary‐like tube formation with a potency similar to that of S1P, while C‐terminal domain of CTGF was slightly less effective. However, N‐terminal domain had only a residual activity in inducing capillary‐like tube formation. Conclusions: This study revealed that CTGF/CCN2 is required for the S1P‐induced endothelial cell migration, which suggests that CTGF/CCN2 may be an important mediator of S1P‐induced physiological and pathological angiogenesis. Moreover, this study shows that the pro‐migratory activity of CTGF/CCN2 is located in the C‐terminal domain.
- 1 September 2007
- Published by Elsevier in Journal of Dermatological Science
- Vol. 47 (3) , 217-226
Distinct effects of gonadectomy in male and female mice on collagen fibrillogenesis in the skin
- 1 September 2007
- Published by Elsevier in Journal of Dermatological Science
- Vol. 47 (3) , 217-226
Distinct effects of gonadectomy in male and female mice on collagen fibrillogenesis in the skin
- 4 September 2004
- Vol. 22, S31-4
The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts.
Latent human cytomegalovirus (HCMV) infection has been implicated in diseases characterized by tissue remodeling. Because of recent evidence indicating the possibility of a partial HCMV reactivation, the purpose of this study was to examine the role of the HCMV immediate early (IE) genes in the regulation of extracellular matrix (ECM) related host genes. Adenoviral vector expressing IE1 was generated to allow efficient gene delivery into human fibroblasts. IE1 stimulated the prolonged expression of connective tissue growth factor (CTGF) and TIMP1. IE1-dependent stimulation of CTGF was partially mediated by TGF-beta. Moreover, whereas collagenous proteins and collagen type 1 mRNA were only transiently induced by IE1 in the majority of fibroblasts, in selected fibroblast strains IE1 induced persistent ECM upregulation for up to 120 hours. This study suggests that transient or limited HCMV reactivation may play a direct role in abnormal matrix remodeling in GVHD, scleroderma, atherosclerosis and other HCMV-linked diseases.
- 4 September 2004
- Vol. 22, S31-4
The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts.
Latent human cytomegalovirus (HCMV) infection has been implicated in diseases characterized by tissue remodeling. Because of recent evidence indicating the possibility of a partial HCMV reactivation, the purpose of this study was to examine the role of the HCMV immediate early (IE) genes in the regulation of extracellular matrix (ECM) related host genes. Adenoviral vector expressing IE1 was generated to allow efficient gene delivery into human fibroblasts. IE1 stimulated the prolonged expression of connective tissue growth factor (CTGF) and TIMP1. IE1-dependent stimulation of CTGF was partially mediated by TGF-beta. Moreover, whereas collagenous proteins and collagen type 1 mRNA were only transiently induced by IE1 in the majority of fibroblasts, in selected fibroblast strains IE1 induced persistent ECM upregulation for up to 120 hours. This study suggests that transient or limited HCMV reactivation may play a direct role in abnormal matrix remodeling in GVHD, scleroderma, atherosclerosis and other HCMV-linked diseases.